ACTRN12614000390684招募中4 期
Adjunctive natural low dose docosahexaenoic acid (DHA) omega-3 in a 16 week random double-blind placebo controlled (RDBPC) cross-over withdrawal study in a group of chronic, psychiatric out-patients with anxiety and mood disorders.
Dr Michael Piperoglou0 个研究点目标入组 60 人开始时间: 2014年4月10日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 20 Years 至 70 Years（—）
- 性别
- All
入选标准
- •1. Outpatients with chronic anxiety and/or depressive symptoms.
- •2. Patients currently taking DHA (NeuroSpark) capsules for at least 3 months prior to study entry.
排除标准
- •2. Brain injury
- •3. Mild cognitive impairment
- •4. Dementias
- •5. Substance dependence and/or abuse
- •6. Schizophrenia
- •7. Acutely suicidal patients
- •8. Chronic unstable medical conditions
研究者
相似试验
已完成
3 期
The DINO TrialACTRN12606000327583ational Health and Medical Research Council657
招募中
3 期
Effect of Docosahexaenoic Acid Supplementation on neonatal outcomes of pereterm infantsutrition of premature babies / Growth of premature babies / Prognosis of premature babies.IRCT20221120056556N2Shahid Beheshti University of Medical Sciences384
已完成
3 期
Effect of omega 3 fatty acid (DHA) Supplementation during pregnancy on newborn birth weight and gestational age .CTRI/2013/04/003540Department of Science and Technology957
进行中（未招募）
不适用
Dietary polyunsaturated fatty acids for decreasing lipid hepatic content in children with fatty liveronalcoholic steatohepatitisMedDRA version: 14.1Level: SOCClassification code 10027433Term: Metabolism and nutrition disordersSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2012-001975-36-ITAZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA
已完成
不适用
To check the docosahexaenoic acid reference ranges in pregnant and normal women population.CTRI/2021/03/031758Department of Pharmaceutical Sciences Guru Nanak Dev University Amritsar164